VERBIO Vereinigte BioEnergie AG Logo

VERBIO Vereinigte BioEnergie AG

0NLY.L

(0.0)
Stock Price

15,50 EUR

5.91% ROA

5.71% ROE

19.24x PER

Market Cap.

1.466.612.148,00 EUR

12.14% DER

0.87% Yield

2.91% NPM

VERBIO Vereinigte BioEnergie AG Stock Analysis

VERBIO Vereinigte BioEnergie AG Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

VERBIO Vereinigte BioEnergie AG Fundamental Stock Analysis
# Analysis Rating
1 ROE

Unidentified ROE

2 ROA

Unidentified ROA

3 PBV

Unidentified ROA

4 DER

Unidentified DER

5 Revenue Growth

Company's revenue has remained stagnant over the past three years, indicating a lack of growth and making it a less favorable option.

6 Net Profit Growth

Throughout the last five years, this company's net profit has remained unchanged, indicating a lack of growth and making it a less favorable investment option.

7 Assets Growth

Regrettably, this company's revenue has shown no signs of growth over the past three years, suggesting limited potential for returns and making it a less appealing choice.

8 Graham Number

Unidentified Graham Number

9 Dividend Growth

Investors should note the company's stagnant dividend growth over the past three years, indicating limited profitability and potentially diminishing returns.

10 Dividend

The company has not distributed any dividends in the past three years, which may raise concerns for investors looking for regular income from their investments.

11 Buffet Intrinsic Value

Based on Warren Buffett's formula, the company's stock seems overpriced (0), indicating a potential drawback for investors as its market price exceeds its estimated intrinsic value.

VERBIO Vereinigte BioEnergie AG Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

VERBIO Vereinigte BioEnergie AG Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Buy
2 MACD Sell
3 RSI Hold
4 Stoch RSI Sell

VERBIO Vereinigte BioEnergie AG Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

VERBIO Vereinigte BioEnergie AG Revenue
Year Revenue Growth
2012 706.336.000
2013 734.149.000 3.79%
2014 618.836.000 -18.63%
2015 654.667.000 5.47%
2016 726.875.000 9.93%
2017 687.079.000 -5.79%
2018 781.380.000 12.07%
2019 873.873.000 10.58%
2020 1.028.614.000 15.04%
2021 1.822.284.000 43.55%
2022 1.977.329.000 7.84%
2023 1.956.492.000 -1.07%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

VERBIO Vereinigte BioEnergie AG Research and Development Expenses
Year Research and Development Expenses Growth
2012 828.000
2013 858.000 3.5%
2014 796.000 -7.79%
2015 1.098.000 27.5%
2016 1.152.000 4.69%
2017 1.406.000 18.07%
2018 3.132.000 55.11%
2019 5.444.000 42.47%
2020 6.227.000 12.57%
2021 6.483.000 3.95%
2022 4.701.000 -37.91%
2023 0 0%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

VERBIO Vereinigte BioEnergie AG General and Administrative Expenses
Year General and Administrative Expenses Growth
2012 24.167.000
2013 0 0%
2014 0 0%
2015 0 0%
2016 0 0%
2017 0 0%
2018 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

VERBIO Vereinigte BioEnergie AG EBITDA
Year EBITDA Growth
2012 1.102.000
2013 32.198.999 96.58%
2014 46.664.000 31%
2015 68.090.000 31.47%
2016 87.363.000 22.06%
2017 43.022.000 -103.07%
2018 96.186.000 55.27%
2019 116.263.000 17.27%
2020 164.503.000 29.32%
2021 481.593.000 65.84%
2022 236.341.000 -103.77%
2023 186.448.000 -26.76%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

VERBIO Vereinigte BioEnergie AG Gross Profit
Year Gross Profit Growth
2012 46.209.000
2013 67.075.000 31.11%
2014 83.515.000 19.69%
2015 106.598.000 21.65%
2016 134.436.000 20.71%
2017 84.450.000 -59.19%
2018 149.215.000 43.4%
2019 184.372.000 19.07%
2020 257.740.000 28.47%
2021 610.890.000 57.81%
2022 362.019.000 -68.75%
2023 376.836.000 3.93%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

VERBIO Vereinigte BioEnergie AG Net Profit
Year Net Profit Growth
2012 -122.989.000
2013 5.699.000 2258.08%
2014 26.780.000 78.72%
2015 48.746.000 45.06%
2016 51.499.000 5.35%
2017 14.923.000 -245.1%
2018 52.968.000 71.83%
2019 63.381.000 16.43%
2020 93.203.000 32%
2021 315.625.000 70.47%
2022 132.024.000 -139.07%
2023 87.208.000 -51.39%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

VERBIO Vereinigte BioEnergie AG Earning per Share (EPS)
Year Earning per Share (EPS) Growth
2012 -2
2013 0 0%
2014 0 0%
2015 1 0%
2016 1 0%
2017 0 0%
2018 1 0%
2019 1 100%
2020 1 0%
2021 5 75%
2022 2 -100%
2023 1 -100%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

VERBIO Vereinigte BioEnergie AG Free Cashflow
Year Free Cashflow Growth
2012 -55.734.000
2013 68.984.000 180.79%
2014 33.094.000 -108.45%
2015 63.334.000 47.75%
2016 56.589.000 -11.92%
2017 -14.117.000 500.86%
2018 44.327.000 131.85%
2019 3.707.000 -1095.76%
2020 50.118.000 92.6%
2021 210.612.000 76.2%
2022 -176.761.000 219.15%
2023 -30.768.000 -474.5%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

VERBIO Vereinigte BioEnergie AG Operating Cashflow
Year Operating Cashflow Growth
2012 -19.511.000
2013 76.407.000 125.54%
2014 46.612.000 -63.92%
2015 76.286.000 38.9%
2016 75.020.000 -1.69%
2017 11.081.000 -577.01%
2018 44.327.000 75%
2019 71.678.000 38.16%
2020 117.183.000 38.83%
2021 325.031.000 63.95%
2022 26.094.000 -1145.62%
2023 19.348.000 -34.87%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

VERBIO Vereinigte BioEnergie AG Capital Expenditure
Year Capital Expenditure Growth
2012 36.223.000
2013 7.423.000 -387.98%
2014 13.518.000 45.09%
2015 12.952.000 -4.37%
2016 18.431.000 29.73%
2017 25.198.000 26.86%
2018 0 0%
2019 67.971.000 100%
2020 67.065.000 -1.35%
2021 114.419.000 41.39%
2022 202.855.000 43.6%
2023 50.116.000 -304.77%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

VERBIO Vereinigte BioEnergie AG Equity
Year Equity Growth
2012 178.307.999
2013 183.544.000 2.85%
2014 209.664.000 12.46%
2015 254.324.999 17.56%
2016 296.391.000 14.19%
2017 300.217.000 1.27%
2018 338.917.000 11.42%
2019 390.823.000 13.28%
2020 509.872.000 23.35%
2021 818.455.000 37.7%
2022 911.827.000 10.24%
2023 945.804.999 3.59%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

VERBIO Vereinigte BioEnergie AG Assets
Year Assets Growth
2012 410.413.000
2013 302.658.000 -35.6%
2014 296.343.000 -2.13%
2015 323.013.000 8.26%
2016 373.079.000 13.42%
2017 365.989.000 -1.94%
2018 424.945.000 13.87%
2019 529.200.000 19.7%
2020 678.621.000 22.02%
2021 1.128.619.000 39.87%
2022 1.297.187.000 12.99%
2023 1.303.201.000 0.46%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

VERBIO Vereinigte BioEnergie AG Liabilities
Year Liabilities Growth
2012 232.105.000
2013 119.114.000 -94.86%
2014 86.679.000 -37.42%
2015 68.688.000 -26.19%
2016 76.688.000 10.43%
2017 65.772.000 -16.6%
2018 86.028.000 23.55%
2019 138.377.000 37.83%
2020 168.749.000 18%
2021 310.164.000 45.59%
2022 385.360.000 19.51%
2023 357.396.000 -7.82%

VERBIO Vereinigte BioEnergie AG Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
29.22
Net Income per Share
1.2
Price to Earning Ratio
19.24x
Price To Sales Ratio
0.78x
POCF Ratio
16.52
PFCF Ratio
-11.86
Price to Book Ratio
1.57
EV to Sales
0.72
EV Over EBITDA
7.95
EV to Operating CashFlow
15.01
EV to FreeCashFlow
-10.87
Earnings Yield
0.05
FreeCashFlow Yield
-0.08
Market Cap
1,47 Bil.
Enterprise Value
1,35 Bil.
Graham Number
19.93
Graham NetNet
-0.37

Income Statement Metrics

Net Income per Share
1.2
Income Quality
1.16
ROE
0.08
Return On Assets
0.04
Return On Capital Employed
0.1
Net Income per EBT
0.56
EBT Per Ebit
0.91
Ebit per Revenue
0.06
Effective Tax Rate
0.44

Margins

Sales, General, & Administrative to Revenue
0
Research & Developement to Revenue
0
Stock Based Compensation to Revenue
0
Gross Profit Margin
0.1
Operating Profit Margin
0.06
Pretax Profit Margin
0.05
Net Profit Margin
0.03

Dividends

Dividend Yield
0.01
Dividend Yield %
0.87
Payout Ratio
0.16
Dividend Per Share
0.2

Operating Metrics

Operating Cashflow per Share
1.4
Free CashFlow per Share
-1.93
Capex to Operating CashFlow
-2.38
Capex to Revenue
-0.11
Capex to Depreciation
-4.84
Return on Invested Capital
0.08
Return on Tangible Assets
0.06
Days Sales Outstanding
20.91
Days Payables Outstanding
22.68
Days of Inventory on Hand
61.65
Receivables Turnover
17.45
Payables Turnover
16.1
Inventory Turnover
5.92
Capex per Share
-3.33

Balance Sheet

Cash per Share
1,89
Book Value per Share
14,71
Tangible Book Value per Share
14.73
Shareholders Equity per Share
14.71
Interest Debt per Share
1.79
Debt to Equity
0.12
Debt to Assets
0.09
Net Debt to EBITDA
-0.72
Current Ratio
2.74
Tangible Asset Value
0,94 Bil.
Net Current Asset Value
0,23 Bil.
Invested Capital
0.12
Working Capital
0,37 Bil.
Intangibles to Total Assets
0
Average Receivables
0,10 Bil.
Average Payables
0,10 Bil.
Average Inventory
262077500
Debt to Market Cap
0.08

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

VERBIO Vereinigte BioEnergie AG Dividends
Year Dividends Growth
2016 0
2017 0 0%
2023 0 0%

VERBIO Vereinigte BioEnergie AG Profile

About VERBIO Vereinigte BioEnergie AG

VERBIO Vereinigte BioEnergie AG produces and supplies biofuels in Germany and rest of Europe. The company's products include biodiesel, bioethanol, biomethane, biosterol, bioglycerin, and liquid fertilizers. The company offers its products to oil corporations, oil traders, independent filling stations, haulage companies, public utilities, and vehicle fleets. VERBIO Vereinigte BioEnergie AG was founded in 2006 and is headquartered in Leipzig, Germany.

CEO
Mr. Claus Sauter
Employee
1.376
Address
Ritterstrasse 23
Leipzig, 04109

VERBIO Vereinigte BioEnergie AG Executives & BODs

VERBIO Vereinigte BioEnergie AG Executives & BODs
# Name Age
1 Mr. Stefan Schreiber
Executive Board Member for North America & Member of Management Board
70
2 Dr. Oliver Ludtke
Chief Technology Officer & Vice-Chairman of the Management Board
70
3 Mr. Olaf Troeber
Chief Financial Officer & Member of Management Board
70
4 Mr. Claus Sauter
Founder, Chairman of Management Board & Chief Executive Officer
70
5 Mr. Bernd Sauter
Executive Board Member for Europe & Member of Management Board
70
6 Mr. Theodor Niesmann
Chief Technology Officer & Member of Management Board
70
7 Ms. Alina Kohler
Head of Investor Relations
70

VERBIO Vereinigte BioEnergie AG Competitors